The arrival of a 750mcg parathyroid hormone injection in Australia has been relatively limited , with access primarily through specialist clinicians and designated hospitals . Early market uptake for this increased strength remain confidential from the supplier , although reports suggest controlled adoption uptake levels . Availability to patients